INTERVIEW

Interview: Celebrating 10 Years of Molly Enabling Patients’ Independence

Nicholas Heaton looks back on the decade since Molly – SHL Medical’s signature two-step autoinjector platform – was launched onto the market, reviewing what made the device platform a success, where Molly is positioned in the market today and how it will continue to evolve to meet the demands of the future.

Interview: GLP-1 Demand and the New Reality of Device Manufacturing Capacity

Andy Wertheim discusses the growing shortage of available manufacturing capacity driven by the boom in GLP-1 therapies, why this means mid-volume development programmes across a range of sectors are struggling to move from development to industrialisation, and how Quvara Medical is ideally positioned to provide the capacity that these programmes lack.

Exclusive Interview: Taking Sustainability Beyond Compliance

Prof Hanns-Christian Mahler

Exclusive Interview: Taking Sustainability Beyond Compliance

Prof Hanns-Christian Mahler engages in a wide-ranging discussion about current challenges and trends in the drug delivery industry, particularly on the topic of sustainability – it’s advantages, difficulties and why companies should aim to do more than the bare minimum required by the regulation.

Interview: Inside The Crux Technology Centre

INDUSTRIALISATION

Stephen Gilmore

Crux Product Design

Interview: Inside The Crux Technology Centre

Stephen Gilmore discusses the opportunities and capabilities unlocked by Crux’s new Technology Centre located in Bristol, UK. Mr Gilmore provides an overview of the new capabilities provided by the facility and the potential it represents to the future of the company.

Sustainable Packaging and Patient-Centric Design

Cambridge Design Partnership

Sustainable Packaging and Patient-Centric Design

Steve Augustyn and Jon Powell discuss a range of key topics in the drug delivery industry, including design complexity, sustainable materials and patient-centric design.

Cardiometabolic Treatments, Rare Diseases, Variable Dosing, and Quanta

Cardiometabolic Treatments, Rare Diseases, Variable Dosing, and Quanta

Bart Burgess discusses some of the key areas for innovation in the industry, such as rare diseases and moving away from variable dosing solutions, and introduces Quanta – SHL's latest product offering.

Automated Testing to Decrease Time-To-Market

Landon Goldfarb

Automated Testing to Decrease Time-To-Market

Landon Goldfarb highlights the advantages conferred by Instron's Cobot automated testing system at both the design verification and production stages of autoinjector development.

Sustainability, Balancing Priorities, and Bringing New Solutions to Market

Sustainability, Balancing Priorities, and Bringing New Solutions to Market

Steven Kaufman discusses the return of sustainability to the centre of drug delivery conversation and how Eco-Inject's novel autoinjector brings fresh thinking to the sector.

Dual-Chamber Syringes, New Partnerships, and Speed-to-Market Pressures Shape 2026

Credence MedSystems

Dual-Chamber Syringes, New Partnerships, and Speed-to-Market Pressures Shape 2026

John Merhige outlines his key themes shaping drug delivery in 2026: new momentum from a dual-chamber syringe fill-finish collaboration, a newly announced commercial supply agreement with a major global pharma company, and growing pressure to deliver increasingly complex molecules faster and more efficiently.

Challenges, Trends, and Recognising Innovation

Laura Armstrong

Challenges, Trends, and Recognising Innovation

Laura Armstrong discusses the challenges and trends currently impacting the drug delivery and pharmaceutical packaging industry.

Interview: Enhancing Clinical Trials with CliniPilot<sup>®</sup> and Clear to Clinic™ Programme

Dr Carolina Canapè

Interview: Enhancing Clinical Trials with CliniPilot^® and Clear to Clinic™ Programme

Dr Carolina Canapè and Roger Lüscher talk with Guy Furness about the application of connectivity in decentralised trials, and how Ypsomed’s CliniPilot and the company’s range of clinic-ready autoinjectors support faster, more efficient and more effective clinical trials.

Interview: Developing Wearable Injectors

EdgeOne Medical

Interview: Developing Wearable Injectors

Liat Shochat discusses her extensive experience in wearable drug delivery device development, covering the various challenges that arise from the inherent complexity of these devices, even with multiple successful wearable devices on the market, as well as the best way to engage with contract development organisations such as EdgeOne Medical.

Interview: New But Not News – A Smooth Transition to USP <382> with Established Expertise

Dr Aurelie Rebuffet

BD (Becton Dickinson & Company)

Interview: New But Not News – A Smooth Transition to USP <382> with Established Expertise

Dr Aurélie Rebuffet and Virginie Jeymond, discuss the new requirements set out in the US Pharmacopeia (USP) Chapter <382>, including the shift towards assessing the drug-device combination product as a holistic whole and how ZebraSci and BD can support pharma companies in complying with USP <382>.

Interview: DARE IDDS – A Long-Term Subcutaneously Implanted Drug Delivery Device

Daré Bioscience

Interview: DARE IDDS – A Long-Term Subcutaneously Implanted Drug Delivery Device

Liz Proos and Ashley Hawson talk exclusively with ONdrugDelivery's Guy Furness about the DARE Intelligent Drug Delivery System – an advanced, connected implantable device that delivers programmable doses for up to a decade – its place in the market, the challenges faced during its design and its potential as novel drug delivery device.

Interview: Aptar Pharma Expansion With New R&D Center

Christophe Pierre

Interview: Aptar Pharma Expansion With New R&D Center

In this interview, Christophe Pierre introduces Aptar Pharma’s new R&D Center in France, and outlines how the new facility will assist the development of smarter, more integrated drug delivery solutions, facilitating progression from concept to full-scale industrialisation across multiple therapeutic fields.

Interview: Integrating Phillips Medisize and Vectura’s Operations

Charlie Schumacher

Phillips Medisize

Interview: Integrating Phillips Medisize and Vectura’s Operations

In this interview, Charlie Schumacher and Sandy Munro discuss Phillips Medisize’s progress on its integration of Vectura, covering aspects such as cultural alignment, technical innovation and the evolving role of CDMOs in the inhalation landscape.

Interview: A Structured Approach to the Eco-Design Process

Fabien de Coninck

Interview: A Structured Approach to the Eco-Design Process

Fabien De Coninck and Bruno Morchain discuss Aptar Pharma’s eco-design philosophy with ONdrugDelivery’s Guy Furness. They cover how Aptar Pharma has implemented lifecycle assessments as a key tool to elucidate the environmental footprint of the company’s rubber components for primary packaging for injectable systems, including how they tackled the unique challenges presented by the complex, proprietary formulations involved in elastomer component design.

Interview: Steven Kaufman. Delivering the Future – Inside the World of Autoinjector Innovation

Portal Instruments

Interview: Steven Kaufman. Delivering the Future – Inside the World of Autoinjector Innovation

Steven Kaufman talks with ONdrugDelivery’s Guy Furness about the world of autoinjectors, looking at the current status quo in the industry, using Portal’s PRIME Nexus™ smart reusable electromechanical autoinjector as a lens to bring into focus how things have changed and where they might be going.

Interview: Making Dual-Chamber Systems a Viable Alternative

Laxman Halleppanavar

Credence MedSystems

Interview: Making Dual-Chamber Systems a Viable Alternative

In this exclusive interview, Laxman Halleppanavar and Guy Furness discuss industry trends and challenges with injectable delivery, and how Credence MedSystems' dual-chamber devices provide solutions to address those challenges. Mr Halleppanavar goes into details of Credence’s role in this increasingly important sector of the drug delivery market, explaining the company’s approach to device design, development and overcoming the barriers posed by supply chain management.

Interview: SHL Advantec – SHL Medical’s New Manufacturing Equipment Sub-Group

Gilbert Fluetsch

Interview: SHL Advantec – SHL Medical’s New Manufacturing Equipment Sub-Group

Gilbert Fluetsch discusses the establishment of SHL Advantec and the foundation it has built as SHL Medical’s in-house equipment specialist. Mr Fluetsch also looks at the role of modular platforms in scaling production and how the company’s global network is designed to support the changing landscape of medical and pharma manufacturing.

Interview From Pilot to Scale Manufacturing

Interview From Pilot to Scale Manufacturing

In this second exclusive interview with ONdrugDelivery, Glenn Svedberg talks with Guy Furness about Nolato’s role as a strategic partner for design, development and industrialisation within the pharmaceutical sector. In an engaging conversation, Mr Svedberg covers a wide range of subjects about Notalo, including the company’s virtual factory, decentralised structure, approach to scaling up from single-cavity moulds to commercial production, regulatory expertise and global footprint, discussing how the company can use each of these elements to support its partners’ device development and industrialisation programmes.

Interview: Phillips Medisize Grows its Capabilities with Vectura

Phillips Medisize

Interview: Phillips Medisize Grows its Capabilities with Vectura

In this exclusive interview with ONdrugDelivery’s Guy Furness, Brian Thompson and Dave Thoreson discuss Phillips Medisize’s expanded capabilities as a result of its recent acquisition of Vectura, bringing extensive expertise and experience in the inhalation sector within the global CDMO. The discussion covers how Phillips Medisize organises its global operations, the opportunities that the acquisition of Vectura represents and where the company goes next.

Interview: PDA Miniverse and Trends in Injectable Drug Delivery

Mathias Romacker

Interview: PDA Miniverse and Trends in Injectable Drug Delivery

In this exclusive interview, Mathias Romacker and Evan Edwards talk with ONdrugDelivery’s Guy Furness about the upcoming inaugural PDA Miniverse conference in Indianapolis, and the topics and trends currently being felt across the injectable drug delivery industry.

Interview: Patient Experience Versus Regulatory Compliance – Can Formulators Find a Middle Ground?

Dr Keat Theng Chow

Interview: Patient Experience Versus Regulatory Compliance – Can Formulators Find a Middle Ground?

Dr Keat Theng Chow outlines the essential themes on Roquette’s radar regarding patient-centric drug design, upcoming regulatory changes and how drug producers can navigate both spheres to the benefit of all.

Interview: Understanding the Impact of USP<382> on Primary Packaging Development

Dr Laure-Helene Guillemot

Interview: Understanding the Impact of USP<382> on Primary Packaging Development

Laure-Hélène Guillemot discusses the new USP <382> chapter coming into force on December 1st, 2025, which will significantly transform functional testing protocols for pharmaceutical companies.

A Sustainable Future for Self-Injection with Connected, Reusable Autoinjectors

Dr Patrick Anquetil

Portal Instruments

A Sustainable Future for Self-Injection with Connected, Reusable Autoinjectors

In this exclusive interview with ONdrugDelivery’s Guy Furness, Dr Patrick Anquetil offers insight into the extensive waste involved in the self-injection market. He explains how pivoting from a model focused on fully disposable devices to reusable electromechanical autoinjectors could offer a more sustainable and cost-effective path forward.

1
2
3
…
5
Next

Top